Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cathelicidin LL-37 improves bone metabolic balance in rats with ovariectomy-induced osteoporosis via the Wnt/beta-catenin pathway

J. Liang, J. Chen, Z. Ye, D. Bao

. 2022 ; 71 (3) : 369-377. [pub] 20220526

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22021456

Osteoporosis is a bone disease characterized by low bone mineral density (BMD) and impaired bone microarchitecture due to the abnormal activity of osteoclasts. Cathelicidins are antimicrobial peptides present in the lysosomes of macrophages and polymorphonuclear leukocytes. LL-37, a cathelicidin, induces various biological effects, including modulation of the immune system, angiogenesis, wound healing, cancer growth, as well as inflammation, and bone loss. A previous study reported direct involvement of LL-37 suppressing osteoclastogenesis in humans. Here, we examined the role of LL-37 in the treatment of osteoporosis using an ovariectomy (OVX) rat model. Our results showed that LL-37 significantly reduced bone loss and pathological injury in OVX rats with osteoporosis. Furthermore, we found that LL-37 significantly increased the activity of the Wnt/beta-catenin pathway in OVX rats with osteoporosis, including the increased expression of beta-catenin, Osterix (Osx), and Runt-related transcription factor 2 (Runx2), whereas XAV-939, an inhibitor of the Wnt/beta-catenin pathway, significantly blocked the effects of LL-37 on bone loss and abnormal bone metabolism. Altogether, our findings suggested that LL-37 exerted a protective role in regulating bone loss and abnormal bone metabolism in rats with osteoporosis by activating the Wnt/beta-catenin pathway.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22021456
003      
CZ-PrNML
005      
20230516113054.0
007      
ta
008      
220907s2022 xr da f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934820 $2 doi
035    __
$a (PubMed)35616038
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Liang, Jianwei $u Department of Orthopedics, The First People’s Hospital of Taizhou, Taizhou, China
245    10
$a Cathelicidin LL-37 improves bone metabolic balance in rats with ovariectomy-induced osteoporosis via the Wnt/beta-catenin pathway / $c J. Liang, J. Chen, Z. Ye, D. Bao
520    9_
$a Osteoporosis is a bone disease characterized by low bone mineral density (BMD) and impaired bone microarchitecture due to the abnormal activity of osteoclasts. Cathelicidins are antimicrobial peptides present in the lysosomes of macrophages and polymorphonuclear leukocytes. LL-37, a cathelicidin, induces various biological effects, including modulation of the immune system, angiogenesis, wound healing, cancer growth, as well as inflammation, and bone loss. A previous study reported direct involvement of LL-37 suppressing osteoclastogenesis in humans. Here, we examined the role of LL-37 in the treatment of osteoporosis using an ovariectomy (OVX) rat model. Our results showed that LL-37 significantly reduced bone loss and pathological injury in OVX rats with osteoporosis. Furthermore, we found that LL-37 significantly increased the activity of the Wnt/beta-catenin pathway in OVX rats with osteoporosis, including the increased expression of beta-catenin, Osterix (Osx), and Runt-related transcription factor 2 (Runx2), whereas XAV-939, an inhibitor of the Wnt/beta-catenin pathway, significantly blocked the effects of LL-37 on bone loss and abnormal bone metabolism. Altogether, our findings suggested that LL-37 exerted a protective role in regulating bone loss and abnormal bone metabolism in rats with osteoporosis by activating the Wnt/beta-catenin pathway.
650    _2
$a zvířata $7 D000818
650    12
$a kationické antimikrobiální peptidy $x farmakologie $7 D023181
650    12
$a kostní denzita $7 D015519
650    _2
$a buněčná diferenciace $7 D002454
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a osteogeneze $7 D010012
650    12
$a osteoporóza $x farmakoterapie $x etiologie $x prevence a kontrola $7 D010024
650    _2
$a ovarektomie $7 D010052
650    _2
$a krysa rodu Rattus $7 D051381
650    12
$a signální dráha Wnt $7 D060449
650    _2
$a beta-katenin $x metabolismus $7 D051176
655    _2
$a časopisecké články $7 D016428
700    1_
$a Chen, Jianjun $u Department of Orthopedics, The First People’s Hospital of Taizhou, Taizhou, China
700    1_
$a Ye, Zhan $u Department of Orthopedics, The First People’s Hospital of Taizhou, Taizhou, China
700    1_
$a Bao, Dandan $u Department of Pharmacy, The First People’s Hospital of Taizhou, Taizhou, China
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, č. 3 (2022), s. 369-377
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35616038 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20220907 $b ABA008
991    __
$a 20230516113051 $b ABA008
999    __
$a ok $b bmc $g 1851686 $s 1172724
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 71 $c 3 $d 369-377 $e 20220526 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK198 $a Pubmed-20220907

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace